Xiao Fang Pharma

603207
21.590.42% ( -0.09 )
Delay Closed: Nov 17, 15:00:00

Valuation

Current ValuationThe current P/E ratio is 18.16, below the reasonable range, cheaper than 86.15% of the time in the past 1 years, and the industry ranks 34/222, the industry Median 22.19.

18.16xP/E
Stock price¥21.68Earnings per share¥1.19

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 22.19x
015304560

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 22.19x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
000538SZYunnan Baiyao
19.19x6.77%¥99.78B
600196SHFOSUN PHARMA
16.97x7.35%¥59.63B
000999SZCR Sanjiu
13.50x3.13%¥43.54B
688578SHAllist
12.63x31.69%¥36.70B
000423SZDEEJ
18.45x9.19%¥33.10B
600079SHHWHG
12.77x28.07%¥32.95B
600566SHJUMPCAN
15.68x--¥28.48B
000513SZLIVZON GROUP
18.23x17.70%¥28.40B
002603SZYILING PHARMACEUTICAL
18.68x14.94%¥25.81B
600535SHTASLY
17.58x17.08%¥21.50B
000623SZJI LIN AO DONG
6.70x--¥20.04B
600380SHJoincare
16.89x15.07%¥19.10B
600062SHCR Double-Crane
10.24x2.02%¥15.95B
600267SHHISUN
12.36x82.61%¥15.14B
600750SHCRJZ
17.63x3.92%¥14.82B
600285SHLingrui Pharma
16.06x9.20%¥13.29B
600664SHHPGC
19.93x71.43%¥12.62B
605507SHGuobang Pharma
19.50x12.03%¥12.13B
300573SZXingqi Pharmaceutical
14.78x--¥11.85B
600993SHMYL
18.29x14.44%¥10.88B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.